Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
about
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price TrendsTwenty years of triptans in the United States Medicaid programs: Utilization and reimbursement trends from 1993 to 2013.Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015.The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
P2860
Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@en
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@nl
type
label
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@en
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@nl
prefLabel
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@en
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@nl
P2093
P2860
P1476
Firm- and drug-specific patter ...... medicaid programs: 1991-2008.
@en
P2093
Boyang Bian
Christina M L Kelton
Edmund A Berry
Jeff J Guo
Lenisa V Chang
Pamela C Heaton
P2860
P2888
P304
P356
10.1007/S40258-014-0083-Z
P577
2014-04-01T00:00:00Z